XHE Quote, Financials, Valuation and Earnings

VanEck Biotech ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.

SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than VanEck Biotech ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than VanEck Biotech ETF.

SPDR S&P Health Care Equipment ETF has a beta of 1.054, which suggesting that the stock is 5.419% more volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.789, suggesting its less volatile than the S&P 500 by 21.104%.

SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.04%. VanEck Biotech ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $1.25 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.

Invesco Biotechnology & Genome ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.

SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than Invesco Biotechnology & Genome ETF.

SPDR S&P Health Care Equipment ETF has a beta of 1.054, which suggesting that the stock is 5.419% more volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.832, suggesting its less volatile than the S&P 500 by 16.774%.

SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.04%. Invesco Biotechnology & Genome ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.03 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.

Invesco Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.

SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than Invesco Pharmaceuticals ETF.

SPDR S&P Health Care Equipment ETF has a beta of 1.054, which suggesting that the stock is 5.419% more volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.638%.

SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.04%. Invesco Pharmaceuticals ETF offers a yield of 1.08% to investors and pays a quarterly dividend of $0.27 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to SPDR S&P Health Care Equipment ETF's net margin of --. SPDR S&P Health Care Equipment ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.

SPDR S&P Health Care Equipment ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Equipment ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe SPDR S&P Health Care Equipment ETF is more attractive than Invesco S&P SmallCap Health Care ETF.

SPDR S&P Health Care Equipment ETF has a beta of 1.054, which suggesting that the stock is 5.419% more volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 1.020, suggesting its more volatile than the S&P 500 by 1.957%.

SPDR S&P Health Care Equipment ETF has a quarterly dividend of $0.03 per share corresponding to a yield of 0.04%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.24% to investors and pays a quarterly dividend of $0.01 per share. SPDR S&P Health Care Equipment ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.

SPDR S&P Health Care Equipment ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. SPDR S&P Health Care Equipment ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, SPDR S&P Health Care Equipment ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Equipment ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.